Producción científica por año
Producción científica por año
Huella digital
Profundizar en los temas de investigación en los que Marcos Restrepo está activo. Estas etiquetas de temas provienen de las obras de esta persona. Juntos, forma una huella digital única.
- 1 Perfiles similares
Colaboraciones y áreas de investigación principales de los últimos cinco años
Colaboración externa reciente a nivel de país/territorio. Para consultar los detalles, haga clic en los puntos o
-
Diagnostic and prognostic trajectories of interstitial lung diseases after the multidisciplinary discussion
Amati, F., Kellogg, D. L., Restrepo, M. I., Blasi, F., Aliberti, S. & Nambiar, A. M., ene 1 2025, En: Therapeutic Advances in Respiratory Disease. 19Producción científica: Article › revisión exhaustiva
Acceso abierto1 Cita (Scopus) -
Enigmatic Roles of Complement Anaphylatoxin Signaling in Health and Disease
Shadid, A., Hok, K. D., Domozhirov, A. Y., Weng-Mills, T., Doursout, M. F., Banda, N. K., Restrepo, M. I. & Shivshankar, P., ago 2025, En: Immune Network. 25, 4, e32.Producción científica: Review article › revisión exhaustiva
Acceso abierto1 Cita (Scopus) -
Functional Roles of the Complement Immune System in Cardiac Inflammation and Hypertrophy
Hok, K. D., Rich, H. E., Shadid, A., Gunamalai, L., Weng-Mills, T., Thandavarayan, R. A., Banda, N. K., Doursout, M. F., Restrepo, M. I. & Shivshankar, P., oct 2025, En: International journal of molecular sciences. 26, 20, 9931.Producción científica: Review article › revisión exhaustiva
Acceso abierto -
Healthcare worker views on antimicrobial resistance in chronic respiratory disease
on behalf of the AMR-Lung Clinical Research Collaboration, dic 2025, En: Antimicrobial Resistance and Infection Control. 14, 1, 1.Producción científica: Article › revisión exhaustiva
Acceso abierto1 Cita (Scopus) -
The 15-Year Survival Advantage: Immune Resilience as a Salutogenic Force in Healthy Aging
STVHCS COVID-19 Convalescent care team, STVHCS Center for Personalized Medicine, South Texas Veterans Health Care System (STVHCS) COVID-19 Clinical team & STVHCS COVID-19 Vaccine team, jul 2025, En: Aging cell. 24, 7, e70063.Producción científica: Article › revisión exhaustiva
Acceso abierto3 Citas (Scopus)
Conjuntos de datos
-
Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study
Kellogg, D. (Creator), Gutierrez, G. C. (Creator), Small, C. E. (Creator), Stephens, B. (Creator), Sanchez, P. (Creator), Beg, M. (Creator), Keyt, H. L. (Creator), Restrepo, M. I. (Creator), Attridge, R. L. (Creator) & Maselli, D. J. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.c.6432757.v1, https://sage.figshare.com/collections/Safety_and_efficacy_of_methylprednisolone_i_versus_i_dexamethasone_in_critically_ill_patients_with_COVID-19_acute_respiratory_distress_syndrome_a_retrospective_study/6432757/1
Dataset
-
Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study
Kellogg, D. (Creator), Gutierrez, G. C. (Creator), Small, C. E. (Creator), Stephens, B. (Creator), Sanchez, P. (Creator), Beg, M. (Creator), Keyt, H. L. (Creator), Restrepo, M. I. (Creator), Attridge, R. L. (Creator) & Maselli, D. J. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.c.6432757, https://sage.figshare.com/collections/Safety_and_efficacy_of_methylprednisolone_i_versus_i_dexamethasone_in_critically_ill_patients_with_COVID-19_acute_respiratory_distress_syndrome_a_retrospective_study/6432757
Dataset
-
Safety and efficacy of methylprednisolone versus dexamethasone in critically ill patients with COVID-19 acute respiratory distress syndrome: a retrospective study
Kellogg, D. (Creator), Gutierrez, G. C. (Creator), Small, C. E. (Creator), Stephens, B. (Creator), Sanchez, P. (Creator), Beg, M. (Creator), Keyt, H. L. (Creator), Restrepo, M. I. (Creator), Attridge, R. L. (Creator) & Maselli, D. J. (Creator), SAGE Journals, 2023
DOI: 10.25384/sage.c.6432757, https://sage.figshare.com/collections/Safety_and_efficacy_of_methylprednisolone_i_versus_i_dexamethasone_in_critically_ill_patients_with_COVID-19_acute_respiratory_distress_syndrome_a_retrospective_study/6432757
Dataset
-
Atypical pathogens in hospitalized patients with community-acquired pneumonia: a worldwide perspective
Gramegna, A. (Creator), Sotgiu, G. (Creator), Di Pasquale, M. (Contributor), Radovanovic, D. (Creator), Terraneo, S. (Creator), Reyes, L. F. (Creator), Vendrell, E. (Creator), Neves, J. (Contributor), Menzella, F. (Creator), Blasi, F. (Creator), Aliberti, S. (Creator) & Restrepo, M. I. (Creator), Figshare, 2018
DOI: 10.6084/m9.figshare.c.4340969.v1, https://springernature.figshare.com/collections/Atypical_pathogens_in_hospitalized_patients_with_community-acquired_pneumonia_a_worldwide_perspective/4340969/1
Dataset
-
In vitro evaluation of aerosol delivery of aztreonam lysine (azli): an adult mechanical ventilation model
Rodríguez, A. (Contributor), Cabrera, M. (Contributor), Reyes, L. F. (Contributor), Bodí, M. (Contributor), Trefler, S. (Contributor), Canadell, L. (Contributor), Barahona, D. (Contributor), Ehrmann, S. (Contributor), Martin-Loeches, I. (Contributor), Restrepo, M. I. (Contributor) & Vecellio, L. (Contributor), Taylor & Francis, 2017
DOI: 10.6084/m9.figshare.5509468.v1, https://tandf.figshare.com/articles/online_resource/In_vitro_evaluation_of_aerosol_delivery_of_aztreonam_lysine_azli_an_adult_mechanical_ventilation_model/5509468/1
Dataset